Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hyder

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Health & Place|February 12, 2008
Observing physical activity in suburbsRichard R Suminski, Jessica Fritzsinger, Tina Leck, et al.
International Journal of Oncology|September 6, 2007
Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cellsYayun Liang, Cynthia Besch-Williford, Indira Benakanakere, et al.
Journal of Steroid Biochemistry|February 1, 1988
High-performance hydrophobic interaction chromatography of estrogen receptors and magnesium dependent protein kinase(s): detection of two molecular forms of estrogen receptors in the presence and absence of sodium molybdateS M Hyder, N Sato, W Hogancamp, et al.
Molecular Carcinogenesis|January 1, 1993
Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis?Z Nawaz, G M Stancel, D P McDonnell, et al.
ACG Case Reports Journal|October 18, 2019
A Successful Steroid-Sparing Approach in Cronkhite-Canada SyndromeEric J Mao, Sarah M Hyder, Thomas D DeNucci, et al.
Endocrine-Related Cancer|December 17, 2008
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot studyIndira Benakanakere, Cynthia Besch-Williford, Mark R Ellersieck, et al.
Breast Cancer (Dove Medical Press)|January 19, 2017
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cellsMatthew T Cook, Yayun Liang, Cynthia Besch-Williford, et al.
Cancer Research|October 19, 2007
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeuticsYayun Liang, Cynthia Besch-Williford, Rolf A Brekken, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 12, 2010
Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley ratsIndira Benakanakere, Cynthia Besch-Williford, Candace E Carroll, et al.
Molecular and Cellular Endocrinology|April 19, 1996
Expression of estrogen receptor variants in normal and neoplastic human uterusC Hu, S M Hyder, D S Needleman, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Health & Place|February 12, 2008
Observing physical activity in suburbsRichard R Suminski, Jessica Fritzsinger, Tina Leck, et al.
International Journal of Oncology|September 6, 2007
Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cellsYayun Liang, Cynthia Besch-Williford, Indira Benakanakere, et al.
Journal of Steroid Biochemistry|February 1, 1988
High-performance hydrophobic interaction chromatography of estrogen receptors and magnesium dependent protein kinase(s): detection of two molecular forms of estrogen receptors in the presence and absence of sodium molybdateS M Hyder, N Sato, W Hogancamp, et al.
Molecular Carcinogenesis|January 1, 1993
Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis?Z Nawaz, G M Stancel, D P McDonnell, et al.
ACG Case Reports Journal|October 18, 2019
A Successful Steroid-Sparing Approach in Cronkhite-Canada SyndromeEric J Mao, Sarah M Hyder, Thomas D DeNucci, et al.
Endocrine-Related Cancer|December 17, 2008
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot studyIndira Benakanakere, Cynthia Besch-Williford, Mark R Ellersieck, et al.
Breast Cancer (Dove Medical Press)|January 19, 2017
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cellsMatthew T Cook, Yayun Liang, Cynthia Besch-Williford, et al.
Cancer Research|October 19, 2007
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeuticsYayun Liang, Cynthia Besch-Williford, Rolf A Brekken, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 12, 2010
Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley ratsIndira Benakanakere, Cynthia Besch-Williford, Candace E Carroll, et al.
Molecular and Cellular Endocrinology|April 19, 1996
Expression of estrogen receptor variants in normal and neoplastic human uterusC Hu, S M Hyder, D S Needleman, et al.
Pageof 13